239 related articles for article (PubMed ID: 10697560)
21. Alteration of ganglioside composition by stable transfection with antisense vectors against GD3-synthase gene expression.
Zeng G; Li DD; Gao L; Birklé S; Bieberich E; Tokuda A; Yu RK
Biochemistry; 1999 Jul; 38(27):8762-9. PubMed ID: 10393551
[TBL] [Abstract][Full Text] [Related]
22. The efficacy of combination therapy using adeno-associated virus--interferon beta and trichostatin A in vitro and in a murine model of neuroblastoma.
Hamner JB; Sims TL; Cutshaw A; Dickson PV; Rosati S; McGee M; Ng CY; Davidoff AM
J Pediatr Surg; 2008 Jan; 43(1):177-82; discussion 182-3. PubMed ID: 18206478
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibodies to gamma-interferon treated LAN-1 cells detect modulation of ganglioside GD2 exposure on human neuroblastoma cells.
Gross N; Beck D; Portoukalian J; Carrel S; Favre S
Anticancer Res; 1989; 9(6):1519-24. PubMed ID: 2516714
[TBL] [Abstract][Full Text] [Related]
24. Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
Brignole C; Pastorino F; Marimpietri D; Pagnan G; Pistorio A; Allen TM; Pistoia V; Ponzoni M
J Natl Cancer Inst; 2004 Aug; 96(15):1171-80. PubMed ID: 15292389
[TBL] [Abstract][Full Text] [Related]
25. Expression of GD2 ganglioside by untreated primary human neuroblastomas.
Wu ZL; Schwartz E; Seeger R; Ladisch S
Cancer Res; 1986 Jan; 46(1):440-3. PubMed ID: 3940209
[TBL] [Abstract][Full Text] [Related]
26. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
[TBL] [Abstract][Full Text] [Related]
27. Medulloblastoma cell-substrate interaction in vitro.
Wikstrand CJ; Friedman HS; Bigner DD
Invasion Metastasis; 1991; 11(6):310-24. PubMed ID: 1822845
[TBL] [Abstract][Full Text] [Related]
28. Selective activity of BS-RNase against anaplastic thyroid cancer.
Kotchetkov R; Cinatl J; Krivtchik AA; Vogel JU; Matousek J; Pouckova P; Kornhuber B; Schwabe D; Cinatl J
Anticancer Res; 2001; 21(2A):1035-42. PubMed ID: 11396137
[TBL] [Abstract][Full Text] [Related]
29. New method for quantitative analysis of GD2 ganglioside in plasma of neuroblastoma patients.
Czaplicki D; Horwacik I; Kowalczyk A; Wieczorek A; Bolek-Marzec K; Balwierz W; Kozik A; Rokita H
Acta Biochim Pol; 2009; 56(3):423-31. PubMed ID: 19724779
[TBL] [Abstract][Full Text] [Related]
30. B4GALNT1 induces angiogenesis, anchorage independence growth and motility, and promotes tumorigenesis in melanoma by induction of ganglioside GM2/GD2.
Yoshida H; Koodie L; Jacobsen K; Hanzawa K; Miyamoto Y; Yamamoto M
Sci Rep; 2020 Jan; 10(1):1199. PubMed ID: 31988291
[TBL] [Abstract][Full Text] [Related]
31. Bovine seminal ribonuclease selectively kills human multidrug-resistant neuroblastoma cells via induction of apoptosis.
Cinatl J; Cinatl J; Kotchetkov R; Vogel JU; Woodcock BG; Matousek J; Pouckova P; Kornhuber B
Int J Oncol; 1999 Nov; 15(5):1001-9. PubMed ID: 10536185
[TBL] [Abstract][Full Text] [Related]
32. Characterization and inhibition of fatty acid synthase in pediatric tumor cell lines.
Slade RF; Hunt DA; Pochet MM; Venema VJ; Hennigar RA
Anticancer Res; 2003; 23(2B):1235-43. PubMed ID: 12820377
[TBL] [Abstract][Full Text] [Related]
33. Selection of novel peptide mimics of the GD2 ganglioside from a constrained phage-displayed peptide library.
Horwacik I; Czaplicki D; Talarek K; Kowalczyk A; Bolesta E; Kozbor D; Rokita H
Int J Mol Med; 2007 May; 19(5):829-39. PubMed ID: 17390090
[TBL] [Abstract][Full Text] [Related]
34. Targeting of ganglioside GD2 monoclonal antibody to neuroblastoma.
Cheung NK; Neely JE; Landmeier B; Nelson D; Miraldi F
J Nucl Med; 1987 Oct; 28(10):1577-83. PubMed ID: 3655911
[TBL] [Abstract][Full Text] [Related]
35. Single-chain Fv-streptavidin substantially improved therapeutic index in multistep targeting directed at disialoganglioside GD2.
Cheung NK; Modak S; Lin Y; Guo H; Zanzonico P; Chung J; Zuo Y; Sanderson J; Wilbert S; Theodore LJ; Axworthy DB; Larson SM
J Nucl Med; 2004 May; 45(5):867-77. PubMed ID: 15136638
[TBL] [Abstract][Full Text] [Related]
36. Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastoma.
Geoerger B; van Beusechem VW; Opolon P; Morizet J; Laudani L; Lecluse Y; Barrois M; Idema S; Grill J; Gerritsen WR; Vassal G
J Gene Med; 2005 May; 7(5):584-94. PubMed ID: 15651070
[TBL] [Abstract][Full Text] [Related]
37. Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: a preclinical model.
Kotchetkov R; Cinatl J; Blaheta R; Vogel JU; Karaskova J; Squire J; Hernáiz Driever P; Klingebiel T; Cinatl J
Int J Cancer; 2003 Mar; 104(1):36-43. PubMed ID: 12532417
[TBL] [Abstract][Full Text] [Related]
38. [Cytomegalovirus infection as a possible factor in the progression of neuroblastoma].
Scholz M; Blaheta RA; Hundemer M; Doerr HW; Cinatl J
Klin Padiatr; 1999; 211(4):310-3. PubMed ID: 10472568
[TBL] [Abstract][Full Text] [Related]
39. Effects of cell surface ganglioside sialidase inhibition on growth control and differentiation of human neuroblastoma cells.
Kopitz J; Mühl C; Ehemann V; Lehmann C; Cantz M
Eur J Cell Biol; 1997 May; 73(1):1-9. PubMed ID: 9174666
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo.
Tanno B; Mancini C; Vitali R; Mancuso M; McDowell HP; Dominici C; Raschellà G
Clin Cancer Res; 2006 Nov; 12(22):6772-80. PubMed ID: 17121898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
